Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
Pre-market 07:05:01 am | |||
34.1 USD | +2.00% | 33.76 | -1.00% |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.66B | Capitalization | 17.37B |
---|---|---|---|---|---|
Net income 2024 * | 703M | Net income 2025 * | 950M | EV / Sales 2024 * | 1.8 x |
Net Debt 2024 * | 9.85B | Net Debt 2025 * | 9.06B | EV / Sales 2025 * | 1.69 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
15.2
x | Employees | 60,000 |
Yield 2024 * |
3.5% | Yield 2025 * |
3.64% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +2.90% | ||
1 week | +0.59% | ||
Current month | +0.03% | ||
1 month | -7.61% | ||
3 months | -16.85% | ||
6 months | -6.70% | ||
Current year | -11.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 254 M€ | +13.69% | - | |
1.87% | 9 M€ | -.--% | ||
1.23% | 17 M€ | +7.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 34.09 | +1.97% | 5,923,067 |
24-05-30 | 33.43 | +0.72% | 3,888,886 |
24-05-29 | 33.19 | -1.95% | 4,258,847 |
24-05-28 | 33.85 | -0.15% | 3,571,396 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.80% | 17.37B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- BAX Stock